Orchid Pharma Limited - Company Profile

Q: Who are the current directors of Orchid Pharma Limited?

The current directors of Orchid Pharma Limited are Mridul Dhanuka, Arjun Dhanuka, Tanu Singla, Dharam Vir, Manish Dhanuka, Sunil Kumar Gupta, Shubha Singh, Ram Gopal Agarwal, Kapil Dayya, Manoj Kumar Goyal.

It is a pharma public limited company based in Chengalpattu, Tamil Nadu, India, established in 1992.

1992 Chengalpattu, Tamil Nadu, India Active

Last Updated: December 15, 2025

Access Report

About Orchid Pharma Limited

Orchid Pharma Limited, a active public limited company, was established on 01 July 1992 in Chengalpattu, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24222TN1992PLC022994. Registered under ROC Roc Chennai. it is listed on BSE: 524372 and NSE: BE : ORCHPHARMA. It has an authorized capital of ₹150.00 Cr and a paid-up capital of ₹50.72 Cr.

Formerly known as Orchid Chemicals & Pharmaceuticals Limited. It upholds a compliant status. In 2024, it reported revenue of ₹849.76 Cr and a net worth of ₹1,218.32 Cr. Employing 1,101 professional, Its leadership includes Mridul Dhanuka (Whole-Time Director), Arjun Dhanuka (Director), Tanu Singla (Director). Past directors included Soundara Kumar, Sundaram Yuvaraj, Maligail Ramkrishna Girinath. It holds ₹366.50 Cr open charges and ₹15,353.51 Cr settled loans. Its latest AGM occurred on 20 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 121-128, 128A-133, 138-151, 159-164, Sidco Industrial Estate,Alathur,Chengalpattu, Chengalpattu, Tamil Nadu, 603110.

Company Details

CIN/LLPIN
L24222TN1992PLC022994
Registration Number
022994
Incorporation Date
01 July 1992
Authorized Capital
₹150.00 Cr
Paid-Up Capital
₹50.72 Cr
ROC Code
Roc Chennai
Listing Status
Listed (BSE: 524372, NSE: BE : ORCHPHARMA)
Company Status
Active

Key Metrics

Authorised Capital ₹ 150.00 Cr as on 15-12-2025
Paid Up Capital ₹ 50.72 Cr as on 15-12-2025
Company Age 33 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 366.50 Cr as on 15-12-2025
Satisfied Charges ₹ 15,353.51 Cr as on 15-12-2025
Revenue Growth **** 23.99% (FY 2024)
Profit Growth **** 74.85% (FY 2024)
Ebitda **** 32.36% (FY 2024)
Net Worth 66.45% (FY 2024)
Total Assets **** 26.89% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Orchid Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Orchid Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Mridul Dhanuka	Whole-Time Director	31 Mar 2020	Current
Arjun Dhanuka	Director	20 Oct 2023	Current
Tanu Singla	Director	29 Jun 2020	Current
Dharam Vir	Director	29 Jun 2020	Current
Manish Dhanuka	Managing Director	31 Mar 2020	Current
Shubha Singh	Director	23 May 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Nominee Director	10 Sep 2018	Past
Pramod Abcsdd	Director	28 May 2015	Past
Pramod Abcsdd	Director	29 Jul 2011	Past
Pramod Abcsdd	Additional Director	29 Jun 2020	Past
Pramod Abcsdd	Additional Director	15 Sep 2015	Past
Pramod Abcsdd	Managing Director	01 Nov 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orchid Pharma.

Orchid Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 23.99% increase. The company also saw a substantial improvement in profitability, with a 74.85% increase in profit. The company's net worth Soared by an impressive increase of 66.45%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

23.99%

*******

Revenue from Operations

*******

23.05%

*******

Total Assets

*******

26.89%

*******

Profit or Loss

*******

74.85%

*******

Net Worth

*******

66.45%

*******

EBITDA

*******

32.36%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orchid Pharma?

In 2024, Orchid Pharma had a promoter holding of 69.84% and a public holding of 30.16%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹3,665,000,000.00

Satisfied Charges

₹153,535,142,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 291.50 Cr
Yes Bank Limited : 75.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
17 Jul 2025	Hdfc Bank Limited	₹142.50 Cr	Open
27 Aug 2022	Yes Bank Limited	₹75.00 Cr	Open
15 Nov 2021	Hdfc Bank Limited	₹149.00 Cr	Open
02 Aug 2023	Hdfc Bank Limited	₹50.00 Cr	Satisfied
06 Jul 2020	Others	₹229.67 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Orchid Pharma?

Orchid Pharma has a workforce of 1101 employees as of Nov 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Orchid Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orchid Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orchid Pharma

Recent Activity within the Organization

Charges

The activity A charge with Hdfc Bank Limited of Rs. 142.50 Cr registered on 17 Jul 2025 with Charge ID 101132171 was modified on 08 Oct 2025. was completed.
08 Oct 2025
Annual General Meeting

The activity Orchid Pharma Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records. was completed.
20 Sep 2025
Charges

A charge with Hdfc Bank Limited amounted to Rs. 142.50 Cr with Charge ID 101132171 was registered on 17 Jul 2025. was recorded as a recent event.
17 Jul 2025
Balance Sheet

Progress on Orchid Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.
31 Mar 2025
Director Appointment

The activity Shubha Singh was appointed as a Director was appointed as a Director on 23 May 2024 & has been associated with this company since 1 year 8 months . was completed.
23 May 2024
Charges

Progress on A charge with Yes Bank Limited of Rs. 75.00 Cr registered on 27 Aug 2022 with Charge ID 100615515 was modified on 10 Jan 2024. was documented.
10 Jan 2024

Explore recent activity and updates - View Recent Activity